Top 10 Companies Leading the Hypromellose Acetate Succinate Market Growth
According to a newly published market research report by 24LifeSciences, global Hypromellose Acetate Succinate market was valued at USD 40.5 million in 2024 and is projected to reach USD 58.9 million by 2031, growing at a compound annual growth rate (CAGR) of 5.6% during the forecast period.
Hypromellose Acetate Succinate (HPMCAS) is a critical pharmaceutical excipient and enteric coating polymer designed to remain intact in the acidic environment of the stomach but dissolve in the more neutral pH of the intestines. This functionality is essential for delayed-release drug formulations, protecting active pharmaceutical ingredients (APIs) from gastric acid and preventing gastric irritation. Its established performance in enabling targeted drug delivery continues to underpin its importance in pharmaceutical development and manufacturing.
Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/7531/hypromellose-acetate-succinate-market
According to a newly published market research report by 24LifeSciences, global Hypromellose Acetate Succinate market was valued at USD 40.5 million in 2024 and is projected to reach USD 58.9 million by 2031, growing at a compound annual growth rate (CAGR) of 5.6% during the forecast period.
Hypromellose Acetate Succinate (HPMCAS) is a critical pharmaceutical excipient and enteric coating polymer designed to remain intact in the acidic environment of the stomach but dissolve in the more neutral pH of the intestines. This functionality is essential for delayed-release drug formulations, protecting active pharmaceutical ingredients (APIs) from gastric acid and preventing gastric irritation. Its established performance in enabling targeted drug delivery continues to underpin its importance in pharmaceutical development and manufacturing.
Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/7531/hypromellose-acetate-succinate-market
Top 10 Companies Leading the Hypromellose Acetate Succinate Market Growth
According to a newly published market research report by 24LifeSciences, global Hypromellose Acetate Succinate market was valued at USD 40.5 million in 2024 and is projected to reach USD 58.9 million by 2031, growing at a compound annual growth rate (CAGR) of 5.6% during the forecast period.
Hypromellose Acetate Succinate (HPMCAS) is a critical pharmaceutical excipient and enteric coating polymer designed to remain intact in the acidic environment of the stomach but dissolve in the more neutral pH of the intestines. This functionality is essential for delayed-release drug formulations, protecting active pharmaceutical ingredients (APIs) from gastric acid and preventing gastric irritation. Its established performance in enabling targeted drug delivery continues to underpin its importance in pharmaceutical development and manufacturing.
Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/7531/hypromellose-acetate-succinate-market
0 Commenti
0 condivisioni
36 Views
0 Anteprima